T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T reg ) and T H 17 differentiation. HIF-1 enhances T H 17 development through direct transcriptional activation of RORgt and via tertiary complex formation with RORgt and p300 recruitment to the IL-17 promoter, thereby regulating T H 17 signature genes. Concurrently, HIF-1 attenuates T reg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1a-deficient T cells are resistant to induction of T H 17-dependent experimental autoimmune encephalitis associated with diminished T H 17 and increased T reg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cellbased immune pathologies.
INTRODUCTION
Host defense against microorganisms requires a complex network of specialized T cell populations that are responsible for triggering inflammation to eradicate the infection, resolving the inflammatory phase after elimination of the threat, and attenuating dysregulated or inappropriate immune responses.
Despite their diverse functions, these T cell subsets largely differentiate from the same pool of precursor naive CD4 + T cells upon stimulation by antigen in the presence of unique cytokine signals that are present in the microenvironment (Murphy and Reiner, 2002; Zhu et al., 2010 ). For instance, T H 1 cells are induced by type 1 interferons and propagated by IL-12; T H 2 cells require IL-4; and T H 17 cells are induced by IL-6 and TGF-b and propagated by IL-23 and IL-21. The activity of all of these effector T cells is attenuated by anti-inflammatory regulatory T cells (T regs ) that inhibit T cell proliferation and autoimmune responses (Barnes and Powrie, 2009; Sakaguchi et al., 2008) . T regs can be induced from naive T cells upon exposure to TGF-b and are propagated by IL-2 (Chen et al., 2003; Davidson et al., 2007; Rajewsky and von Boehmer, 2008) . T reg are commonly categorized into thymus-derived natural T reg (nT reg ) and induced T reg (iT reg ). Both iT reg and nT reg express Foxp3 as a core subset-specific transcription factor, which activates a large bank of genes that mediate the suppressive phenotype of T reg and also silences many effector T cell genes (Getnet et al., 2010; Pan et al., 2009; Sakaguchi et al., 2008) . TGF-b has been shown to maintain peripheral nT reg cells that develop in the thymus, and its deficiency leads to the development of early lethal autoimmunity. Moreover, TGF-b induces Foxp3 expression in peripheral naive T cells, leading to the differentiation of iT regs , which exhibit a suppressive phenotype similar to that seen in nTreg cells (Sakaguchi et al., 2008) .
T H 17 and T reg cells share a common requirement for TGF-b in their differentiation requirements despite expressing distinct transcriptional regulators (RORgt versus Foxp3, respectively) and demonstrating opposing functions (inflammatory versus anti-inflammatory) (Bettelli et al., 2006; Dong, 2008; Littman and Rudensky, 2010; Mangan et al., 2006; O'Quinn et al., 2008; Veldhoen et al., 2006) . T H 17 cells are important in responses mounted against extracellular bacterial infections of the intestine and the airways (Korn et al., 2009) . Despite providing a benefit in these settings, T H 17 can play a pathologic role in the induction of several autoimmune diseases, including collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), inflammatory bowel diseases (Fife et al., 2009; Weaver et al., 2007; Wu et al., 2009) , and inflammation-induced carcinogenesis . In these models, T reg -mediated suppression of T H 17 responses often plays a protective role against pathology associated with the disease (Ahern et al., 2010) .
In addition to TGF-b, initial T H 17 priming also requires the cooperative action of IL-6 signaling. Subsequently, IL-23 and IL-21 play a key role in the maintenance of T H 17 differentiation by enhancing the transcription of IL-17 and other T H 17 signature cytokines (Korn et al., 2009; Littman and Rudensky, 2010) . Interestingly, IL-6, IL-21, and IL-23 all activate Stat3, which is critical for the effects of these cytokines on T H 17 cell differentiation (Zhou et al., 2008; Harris et al., 2007) . Though it is now known that Stat3 induces RORgt gene expression (Harris et al., 2007; Yang et al., 2007) -the key transcription factor required for T H 17 development (Ivanov et al., 2006) -the mechanism by which this is accomplished remains unclear. Interestingly, the defect in T H 17 differentiation seen in the absence of Stat3 can be only partially rescued by RORgt overexpression (Yang et al., 2008b) . Furthermore, although Stat3 binds most of the genes that have been shown to promote T H 17 cell fate determination, it also binds to many genes that are involved in T cell survival and proliferation (Durant et al., 2010) . Genes bound by RORgt, on the other hand, are fairly specific for the T H 17 differentiation program. Clearly, additional regulators contribute to the control of the T H 17 transcriptional program.
Interestingly, accumulating evidence suggests that T H 17 and iT reg arise from a common precursor. In response to TGF-b in vitro as well as in vivo, many T cells coexpress RORgt and Foxp3 (Veldhoen et al., 2006; Yang et al., 2008a) . Ultimately, depending on the interplay between additional environmental cues, such as the relative amounts of IL-6 and TGF-b, one or the other subset emerges as the dominant phenotype. High TGF-b levels in the absence of IL-6 induce Foxp3 and repress IL-23R transcription. Foxp3 can, in turn, bind to the RORgt protein and antagonize its ability to bind DNA, thus pushing T cell differentiation away from the T H 17 transcriptional program and toward the T reg lineage. On the other hand, proinflammatory cytokines, such as IL-6 or IL-21 in the presence of low TGF-b, activate Stat3, which overcomes Foxp3 inhibition of RORgt transcriptional activity. This leads to the upregulation of the IL-23R, thus pushing T cell differentiation toward a T H 17 fate (Zhou et al., 2008) . Ultimate T H 17 differentiation is associated with Foxp3 downregulation and sustained, unopposed RORgt and Stat3 transcriptional activity, although the mechanisms underlying Foxp3 suppression during T H 17 lineage commitment are not fully understood.
In this study, we explored the role of a key metabolic sensor and regulator in T cell fate determination. We report that hypoxia-inducible factor 1 (HIF-1), the transcription factor that mediates the metabolic switch from oxidative phosphorylation to aerobic glycolysis in response to hypoxia (Semenza, 2007) , in fact regulates the T H 17/T reg balance. Specifically, we have discovered that HIF-1 promotes T H 17 differentiation by directly inducing RORgt transcription and subsequently collaborates with RORgt to regulate downstream T H 17 genes. In addition, HIF-1 inhibits T reg differentiation through an active process that targets Foxp3 protein for degradation. Given the plasticity between T H 17 and T reg programs, our study sheds light on how this balance is subject to metabolic regulation and suggests new strategies to manipulate these cell lineage decisions in order to treat diseases associated with T H 17/T reg imbalance.
RESULTS
HIF-1a Expression Is Upregulated in a Stat3-Dependent Manner in T Cells under T H 17-Skewing Conditions HIF-1 is a heterodimeric transcription factor consisting of a highly regulated oxygen-sensitive HIF-1a subunit and a constitutively present b subunit (termed HIF-1b) (Semenza, 2007) . HIF-1a expression in T cells can be induced both by hypoxic and nonhypoxic stimuli, including TCR-triggered and PI3K-mediated pathways, that result in mRNA upregulation and protein stabilization (Lukashev et al., 2006) . Intrigued by a potential link between the requirement for Stat3 in the T H 17 program and our previous observation that HIF-1a is a target gene for activated Stat3 in tumor cells (Harris et al., 2007; Xu et al., 2005) , we tested the hypothesis that HIF-1a plays a positive role in T H 17 development. We began by analyzing HIF-1a mRNA expression in helper T cell subsets using qRT-PCR and found that HIF-1a mRNA was most highly expressed in T H 17 cells ( Figure 1A ). When naive T cells were activated in the presence of TGF-b + IL-6 (T H 17-skewing conditions), HIF-1a mRNA increased, peaked after 48 hr of culture, and then began to decline ( Figure 1B ) relative to consistently low background signal established using HIF-1a knockout (HIF-1a À/À ) T cells (generated by crossing CD4 cre 3
HIF-1a
flox/flox mice, termed T-HIF-1 À/À mice). T-HIF-1 À/À mice had normal development of CD4 + and CD8 + T cells, B cells, and dendritic cells ( Figure S1 available online). Whereas wildtype (WT) T cells activated under T H 17-skewing conditions accumulated IL-17A and RORgt transcripts over time, the induction of these T H 17-associated mRNAs by HIF-1a deficient T cells was minimal ( Figure 1C and 1D ). Because HIF-1a mRNA was upregulated during in vitro T H 17 differentiation and RORgt and IL-17A mRNA induction were significantly diminished in the absence of HIF-1a, we suspected that HIF-1a regulates important components of the T H 17 pathway. Furthermore, we measured HIF-1a and HIF-1b protein in T cells stimulated with differing levels of IL-6 and TGF-b. Whereas HIF-1b expression was constitutive as expected under all treatments, both TGF-b and IL-6 alone induced HIF-1a, and the combination of the two generated significantly higher levels of HIF-1a protein-even under normoxic conditions ( Figure 1E Figure 1E ). Furthermore, a chromatin immunoprecipitation (ChIP) experiment was carried out to test whether Stat3 directly induces HIF-1a gene expression in T H 17 cells. Stat3 was directly associated with the promoter region of HIF-1a in the WT T H 17-skewed T cells, but not at the promoter region of GAPDH ( Figure 1F ). These findings confirm that HIF-1a expression is induced in T cells during T H 17 differentiation in a Stat3-dependent manner. Figure 2C ). This induction of IL-17A was associated with the upregulation of both RORgt mRNA and protein ( Figure S2 ). The IL-17A + cell population was also significantly increased upon overexpression of HIF-1a under T H 17-skewing conditions (Figure 2C, right) . These results support the notion that HIF-1a might facilitate T H 17 development through the upregulation of RORgt. The fact that HIF-1a is a major sensor of metabolic cues, such as oxygen tension, suggests that this protein could be an important link between metabolism and T cell fate determination. To formally test this, we asked whether hypoxia, which stabilizes HIF-1a protein levels and subsequent transcriptional activity, could affect T H 17 differentiation. Indeed, after T H 17 skewing, we observed a higher proportion of IL-17A + cells in hypoxic compared to normoxic culture conditions. This increase was abrogated in HIF-1a À/À T cells (Figure 2D and Figure S2E ), indicating that the hypoxia-induced enhancement of T H 17 differentiation is HIF-1a dependent. These findings support the idea that metabolic cues modulate T cell differentiation and that HIF-1 is an important mediator of this effect. HIF-1a Activates RORgt Transcription and Cooperates with RORgt and p300 to Activate the IL-17A Gene during T H 17 Development Next, we sought to further dissect the molecular mechanism by which HIF-1a regulates T H 17 development. Given that RORgt is a key transcriptional regulator of T H 17 cells, as well as the dramatically blunted induction of RORgt observed in HIF-1a
T cells ( Figure 1D ), we determined whether HIF-1a directly regulates RORgt gene expression. We used a reporter assay with the luciferase gene under the control of the 1.1 kb RORgt promoter (Figures S3A and S3B) . Transfection of Jurkat cells with the RORgt promoter-driven reporter construct, together with increasing amounts of HIF-1a-encoding plasmid, indeed caused corresponding increases in RORgt promoter activity, particularly upon PMA and ionomycin stimulation ( Figure S3C ). Analysis of the RORgt promoter sequence revealed that a hypoxia response element (HRE, a conserved HIF-1a-binding site) is located in the proximal region of the RORgt promoter ( Figure S3A ). To further assess the importance of HIF-1a in RORgt promoter activation, we tested the reporter activity of a promoter with mutated HIF1a-binding sites ( Figure S3B ). The mutated constructs had much lower luciferase activity compared to that of a wild-type RORgt promoter-driven luciferase reporter ( Figure 3A) . Likewise, the expression of a Hif1a mutant gene lacking the DNA-binding domain failed to activate the wild-type RORgt promoter (Figure 3B) . Because the human and mouse RORgt promoter sequences share a high degree of identity as well as a conserved HRE ( Figure S3A ), we also tested the importance of HIF-1a in activation of the human RORgt promoter. Luciferase assays using the human sequence demonstrated that HIF-1a activates this promoter in a similar fashion to that of the mouse ( Figures  S3D and S3E ). These results suggest that HIF-1 can regulate RORgt gene expression. To further dissect this mechanism, a ChIP assay was employed to test whether HIF-1a directly binds to the promoter region of the RORgt gene in primary, in vitro-generated T H 17 See also Figure S3 .
cells. Indeed, HIF-1a was found to bind to the HRE located at the RORgt promoter, but not the promoter of the non-HIF-1a-regulated Gmpr gene ( Figure 3C and Figures S4A-S4D Figure 4A ). In striking contrast to our findings with the RORgt promoter, a HIF-1a mutant with a characterized DNA-binding domain deletion (Arany et al., 1996) showed no defect in inducing reporter gene activity, which implies that DNA binding is dispensable for HIF-1a-mediated IL-17A expression. Because the DNA-binding domain of HIF-1a did not appear to be required for its function in facilitating RORgt activity, we speculated that HIF-1a might physically associate with RORgt, serving as a coactivator for RORgt without direct DNA binding. To test this hypothesis, a Flag-tagged HIF-1a plasmid was coexpressed with Myc-tagged RORgt in Jurkat T cells. HIF-1a was found to coimmunoprecipitate (co-IP) with RORgt ( Figure S4E ). The association between HIF-1a and RORgt was further confirmed by co-IP of endogenous HIF-1a and RORgt in T cells cultured under T H 17-skewing conditions ( Figure 4B ). To verify that the interaction between HIF-1a and RORgt was direct, we employed affinity-purified recombinant GST fusion proteins to pull down Myc-RORgt from 293T cell lysate. GST-HIF-1a (amino acids1-80), rather than GST alone, was bound to RORgt (Figure S4F) . Further testing this apparent direct association of RORgt and HIF-1a, we purified His-tagged RORgt from E. coli, and a GST pull-down assay was carried out using GST or GST-HIF-1a fragments as indicated. Only GST fusions of the HIF-1a N terminus (1-80 aa), but not GST alone or other HIF-1a fragments, successfully pulled down RORgt ( Figure 4C ). Taken together, these results suggested a direct interaction between the two proteins in vitro.
Because it has been shown that the transcription factor p300 is critical for HIF-1a-mediated gene activation under hypoxic conditions, we hypothesized that HIF-1a might function in a complex with RORgt by recruiting p300 to activate target genes such as IL-17A. To test this hypothesis, a ChIP assay was employed to determine whether RORgt, HIF-1a, and p300 associate with the IL-17A promoter during T H 17 differentiation. Indeed, we detected localized binding of RORgt, HIF-1a, and p300 to the IL-17A promoter determined using primers flanking the RORgt-binding site located at the IL-17A promoter region ( Figure 4D ). This binding, as analyzed by ChIP, was specific because no significant signal could be detected at a nonRORgt-binding region within the IL-17A promoter. Furthermore, ChIP analysis revealed that HIF-1a was recruited to several other putative RORgt-binding regions, including CNS2. This recruitment of HIF-1a was dependent on RORgt because it was abrogated in T cells from RORgt knockout mice (Figures S5A-S5D ). Additionally, we observed similar colocalized binding of RORgt, HIF-1a, and p300 at the promoters of the T H 17 signature genes IL-17F and IL-23R ( Figure 4E ). The role of the RORgt/HIF-1a/ p300 complex in the activation of the IL-17A promoter was further confirmed by reporter assays in Jurkat and 293T cells. Surprisingly, coexpression of RORgt, HIF-1a, and p300 led to a more than 10-fold increase in luciferase activity compared to that induced by combinations of any two of these proteins ( Figures S5E and S5F ). However, a HIF-1a mutant with a C-terminal deletion of the p300-binding domain (Arany et al., 1996) failed to synergize with RORgt and p300 in the activation of the IL-17A promoter, implying that p300 is required for the full function of RORgt and HIF-1a in the regulation of IL-17A gene expression ( Figure S5E ). In addition, IL-17A production in Jurkat T cells cotransfected with plasmids encoding RORgt, HIF-1a, and p300 was further increased under hypoxic conditions ( Figure 4F ). These results suggest that, though active under normoxic conditions, HIF-1a's ability to promote IL-17A production is indeed modulated by oxygen tension. Of note, the gut, which is known to be relatively hypoxic under physiologic conditions (Koch, 2002) , contains a high proportion of IL-17A-producing cells. We found that, under steady-state conditions, T-HIF-1 À/À mice had reduced proportions of IL-17A + cells in the lamina propria ( Figures S6A-S6D ), indicating a potential role for HIF-1a in promoting T H 17 development in the context of microbial influences. p300 possesses histone acetyltransferase (HAT) activity (Thompson et al., 2004) . In order to determine whether this HAT activity is required for the RORgt/HIF-1a /p300 complexmediated IL-17A gene expression, we performed cotransfection studies using a p300 mutant with a HAT domain deletion (Dp300) (Youn et al., 2000) . Wild-type p300, but not Dp300, could synergistically enhance IL-17A promoter activity in the presence of HIF-1a and RORgt ( Figure S5E ). Furthermore, a HIF-1a mutant with a deletion in its p300-binding domain (Arany et al., 1996) fails to activate the IL-17A promoter. These findings indicate that RORgt and HIF-1a, through recruitment of p300 to the IL-17A promoter, acetylate histones to ''open'' the chromatin structure and facilitate gene expression. In support of this notion, ChIP assays revealed that histones H3 and H4 around the IL-17A promoter region were highly acetylated in WT compared to HIF-1a À/À T cells under T H 17-inducing conditions ( Figure 4G ).
Similarly, hyperacetylated histones H3 and H4 were associated with the promoter of T H 17 signature genes IL-17F and IL-23R in WT, but not in HIF-1a
, T H 17 cells ( Figures S6E and S6F ). Taken together, these results demonstrate that HIF-1 plays a dual role in regulating IL-17A transcriptional activity by directly activating RORgt transcription and then associating with RORgt at the IL-17A promoter to recruit p300, thus generating a permissive chromatin structure. (C) RORgt interacts with the N terminus of HIF-1a. His-tagged RORgt purified from E. coli was incubated with different fragments of GST-HIF-1a also purified from E. coli as indicated, followed by pull-down with GST beads, resolution by SDS-PAGE, and Western blotting with anti-RORgt (top and bottom) antibodies, or anti-GST (middle).
HIF-1a Mediates Foxp3 Protein Degradation during T H 17 Development

(D and E) FACS-sorted CD4 + T cells from WT or HIF-1a
À/À mice were activated under T H 17-skewing conditions (as described for B) prior to harvest for ChIP assay utilizing anti-RORgt, anti-HIF-1a, or anti-p300 antibodies.
(F) Hypoxia enhances the activation of IL-17 promoter-driven luciferase activity by HIF-1, RORgt, and p300. Jurkat T cells were transfected with a IL-17 promoterdriven luciferase reporter along with the indicated plasmids under normoxia or hypoxia, followed by stimulation and assessment as described for Figure 3B . (G) Histone hyperacetylation at the IL-17 promoter was detected by ChIP assay in WT and HIF-1a À/À T cells under T H 17-skewing conditions for 5 days.
(D-G) Mean + SD of at least three independent experiments. See also Figure S4 , Figure S5 , Figure S6 , and Table S1 . Figure 5B and 5C). These findings suggest that, under both T reg -and T H 17-skewing conditions, HIF-1a downregulates Foxp3 protein levels despite demonstrating no effect on Foxp3 mRNA levels ( Figure 5A ). Based on these findings, we sought to determine whether Foxp3 levels were sensitive to hypoxia. T cells were thus cultured with TGF-b and IL-2 under hypoxic conditions. Foxp3 + cells were significantly decreased (I and J) Naive T cells were cultured under Treg-skewing conditions in normoxia (N) or hypoxia (H) for 4 days. Cells were harvested and lysed, followed by immunoprecipitation with anti-Foxp3 or control IgG antibodies. The pulled down protein along with an input control were resolved by SDS-PAGE, followed by western blot. Depicted are typical findings from three independent experiments. Data shown are representative of at least three independent experiments (mean + SD). See also Figure S7 .
under these hypoxic conditions relative to normoxia ( Figure 5D ). Thus, hypoxic culture conditions have opposite effects on IL-17 and Foxp3 induction. Compatible with this in vitro finding, steady-state levels of Foxp3 + cells in the lamina propria of the gut, which, as indicated above (Koch, 2002) , is relatively hypoxic, are significantly increased in T-HIF-1 À/À mice ( Figures   S6A-S6D ).
We next asked whether a physical interaction between Foxp3 and HIF-1a existed. Immunoprecipitation and western blot analysis of 293 T cells cotransfected with plasmids encoding HIF-1a and Foxp3, in fact, demonstrated a physical interaction between these two molecules ( Figure S7A ). This interaction between HIF-1a and Foxp3 was further confirmed by endogenous co-IP in iT reg cells ( Figure 5E ). The HIF-1a-binding domain was further mapped to the C terminus of Foxp3 ( Figure S7B) , and the Foxp3-binding domain in HIF-1a was found to be within the N-terminal 80 amino acids by GST pull-down experiments (Figure S7C ). Based on these results, we sought to determine whether HIF-1a could regulate Foxp3 protein levels through a mechanism completely distinct from its classic role as a transcriptional regulator. In particular, we hypothesized that HIF-1 might target Foxp3 for degradation. Indeed, upon cotransfection of 293T cells with Foxp3 and increasing amounts of Flag-tagged HIF-1a, Foxp3 protein levels progressively decreased (Figure 5F ). On the other hand, RORgt protein levels remained unchanged upon cotransfection with HIF-1a ( Figure S7D ). It has been well established that ubiquitin-dependent degradation of HIF-1a itself occurs via proline hydroxylation at amino acid positions 402 and 564 by prolyl hydroxylases (PHDs). Hydroxylated HIF-1a is subsequently bound by the von Hippel-Lindau protein (VHL), which recruits the Elongin-C-Elongin-B-Cullin-2-E3-ubiquitin ligase complex, thereby targeting HIF-1a for degradation by the 26S proteasome (Semenza, 2007) . We wondered whether HIF-1a's ability to induce Foxp3 protein degradation was dependent on this very mechanism. To address this, we cotransfected 293T cells with Foxp3 and a HIF-1a mutant in which prolines 402 (p402A) and 564 (p564A) were mutated to alanines, making HIF-1a resistant to both hydroxylation by PHDs and subsequent proteasomal degradation. The expression of P402A and P564A HIF-1a failed to induce Foxp3 degradation ( Figures 5G  and 5H ). Similar cotransfection assays using a HIF-1a plasmid containing an oxygen dependent domain (ODD) deletion (CA5-HIF-1a) further demonstrated that a nonproline hydroxylatable HIF-1a was incapable of mediating Foxp3 degradation ( Figures  5G and 5H) . Knockdown of PHD2 with siRNA also eliminated the ability of wild-type HIF-1a to mediate the degradation of Foxp3 ( Figure S8A ). HIF-1a-mediated Foxp3 degradation was completely inhibited in the presence of a proteasome inhibitor ( Figure S8B ). Furthermore, we assessed whether Foxp3 itself could be ubiquitinated under hypoxic conditions in primary iT regs . Hypoxic culture significantly enhanced both Foxp3 ubiquitination and degradation in these cells (Figures 5I and 5J) . Furthermore, this ubiquitin-mediated Foxp3 degradation process could be prevented by addition of the proteasomal inhibitor MG132 to iT reg cells under hypoxia. Collectively, these results are compatible with a scenario in which HIF-1 mediates Foxp3 degradation via PHD-VHL-ubiquitin-mediated proteasomal degradation, although future studies are needed to delineate precisely how HIF-1a protein turnover dynamics in T cells modulate Foxp3 levels.
Collectively, these in vitro differentiation studies, alongside our transcriptional and biochemical analyses, suggest a model in which HIF-1a is transcriptionally activated via Stat3 signaling in differentiating T cells, resulting in the enhancement of the T H 17 genetic program via a RORgt/p300-dependent mechanism and repression of the T reg transcriptional program through induced degradation of Foxp3.
Mice with HIF-1a-Deficient T Cells Fail to Mount a Strong T H 17 Response, Have Increased T reg Numbers, and Are Resistant to EAE Our in vitro findings that HIF-1a regulates the T H 17/T reg balance prompted us to test its role in vivo in the setting of a pathologic T H 17-dependent autoimmune disease. T H 17 cells are the major pathogenic population in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, although factors besides IL-17A and IL-17F can contribute to the disease. Immunization of B6 mice with myelin oligodendrocyte glycoprotein peptide ) in complete Freund's adjuvant (CFA) induces a T H 17-dependent response that induces encephalitis. After a peak of encephalitis, clinically discernible by various gradable neurologic signs (including tail paralysis, progressing to hind and front limb paralysis), the disease remits, concomitant with expansion of T regs that can silence the T H 17 encephalitic process. Strikingly, WT mice immunized with MOG 35-55 developed EAE, whereas T-HIF-1a À/À mice were highly resistant ( Fig This altered balance between T reg cells and T H 17 cells exactly parallels our in vitro culture studies and suggests that HIF-1a indeed plays a role in modulating the T H 17/T reg balance. Taken together, these results support the notion that HIF-1 plays a role in setting the T H 17/T reg balance in a T H 17-dependent disease model and that the mechanisms defined in the in vitro differentiation assays are also operative in vivo (Figure 7 ).
DISCUSSION
Here, we identify HIF-1 as a major player in the development of T H 17 cells and further demonstrate its role in modulating the T H 17:T reg balance. Specifically, HIF-1 promotes T H 17 development through: (1) direct transcriptional activation of RORgt, the major T H 17 transcription factor, and (2) direct collaboration with RORgt to activate T H 17 signature genes, such as IL-17A, through mechanisms involving p300 recruitment and histone acetylation. Other transcription factors have been identified to contribute to the induction of IL-17A in T H 17-polarized cells: Runx1 (Zhang et al., 2008) , BATF (Schraml et al., 2009 ), Stat3, c-Maf (Bauquet et al., 2009 , AHR (Veldhoen et al., 2008) , and RORa (Yang et al., 2008b) . Interestingly, like most of these factors, HIF-1a not only regulates RORgt expression at the mRNA level, but also cooperates with RORgt protein to regulate IL-17A-related genes during T H 17 development. HIF-1 may promote the T H 17 response in additional ways. Indeed, studies by Miossec and colleagues indicate that the hypoxia-induced pathway is itself activated by IL-17A and IL-17F (Hot and Miossec, 2011) , suggesting that IL-17 signaling can sustain the HIF-1 pool and thereby perpetuate an existing T H 17response. Coordinate with these transcriptional mechanisms for the promotion of T H 17 development, HIF-1 inhibits differentiation toward the T reg lineage through a distinct, nontranscriptional mechanism. We show that HIF-1 targets Foxp3 for ubiquitination and proteasomal degradation, using the same ubiquitin ligase system that is responsible for degradation of HIF-1a itself (Figure 7) .
Our findings help to clarify the molecular events involved in lineage differentiation from the precursors of T H 17 and T reg cells into the distinct T cell subsets. In addition, because HIF-1 responds to metabolic cues, our findings link metabolism to T cell differentiation and provide a basis for understanding how the metabolic environment of a T cell can modulate its fate decisions. Our studies on HIF-1 presented here and those of Delgoffe et al. (Delgoffe et al., , 2011 
T-HIF-1a
À/À mice failed to develop the severe disease seen in HIF-1a +/+ mice. Mean scores for HIF-1a +/+ and T-HIF-1a À/À mice over time are represented (± SEM; *p < 0.05). Shown is a representative of four experiments (n = 7-10 per group).
(B and C) During peak disease (day12), draining lymph node, splenic, and CNS-infiltrating T cells were recovered and stained for IL-17 and IFNg. The mean percentage of CNS CD4 + cells during peak disease (days 12-14) that were positive for IL-17 was determined (C).
(D and E) Similarly, during the recovery phase (day 21), tissue-infiltrating cells were isolated, and the percentage of CD4 + that were Foxp3 + was found (D and E).
(C) and (E) present the mean (± SEM; *p < 0.05) of at least three trials, and dot plots are representative analyses.
further link metabolic sensing and cytokine signaling in T cell fate determination. HIF-1 is a major sensor of oxygen tension, and indeed, we found that T H 17 differentiation is enhanced under hypoxia in a HIF-1a-dependent manner. Interestingly, a number of studies have demonstrated that inflammatory environments are relatively hypoxic. It is therefore likely that HIF-1a activity represents a major mechanism by which the hypoxic conditions associated with inflammation can promote T H 17 differentiation. It is quite clear, however, that HIF-1a protein is readily detectable in T H 17 cells under normoxia, and the experiments utilizing HIF-1a À/À T cells confirm that, under such conditions, T H 17 differentiation is significantly impaired without HIF-1a. Even though HIF-1 was originally discovered as a hypoxia sensor, it is now well appreciated that HIF-1a levels can be significantly affected by many other important metabolites such as reactive oxygen species and succinate (Pouyssé gur and MechtaGrigoriou, 2006) . This regulation appears to be at the level of PHD enzyme activity, which in normoxia hydroxylates specific prolines on HIF-1a, targeting it for VHL-dependent ubiquitination and proteosomal degradation. Our findings regarding the role of HIF-1 in targeting Foxp3 for degradation help to explain the unresolved question of how dual T H 17/T reg precursors that express both RORgt and Foxp3 eventually eliminate Foxp3 when they commit to T H 17 differentiation in a STAT3-dependent fashion. Rudensky and colleagues have recently proposed that conserved noncoding sequence 2 (CNS2) in the Foxp3 gene represents a site for positive transcriptional autoregulation of Foxp3, providing a mechanism for the protein to maintain its own expression levels (Zheng et al., 2010) . Thus, degradation of Foxp3 in T H 17/T reg progenitors mediated by HIF-1 would be expected to eventually diminish Foxp3 gene transcriptional activity, thereby antagonizing stable Foxp3 autoregulation and consequent T reg lineage commitment.
Sitkovsky and colleagues have suggested that HIF-1 activity in T cells is a general negative regulator of T cell activation (Lukashev et al., 2006) . These experiments did not evaluate specific T cell differentiation decisions, however. We found that neither IFN-g nor IL-4 production was significantly affected by the absence of HIF-1 in T cells cultured under Th1 or Th2 conditions, respectively. Because T H 17 cytokines can inhibit Th1/IFN-g development in some circumstances (Luger et al., 2008) , it is possible that the enhanced IFN-g production seen in HIF-1a
T cells under the nonskewing in vitro conditions used by Lukashev et al. is, in fact, a reflection of diminished T H 17 development.
Our in vivo findings demonstrate that mice with HIF-1a
T cells are resistant to induction of EAE, a T H 17-dependent disease whose remission is dependent upon T reg cells (Schraml et al., 2009) . These experiments validate the role of HIF-1a identified by our in vitro studies and further suggest the possibility of metabolically modulating autoimmune diseases. Indeed, there is great interest in developing HIF-1a inhibitors based on its role in cancer. It would be worthwhile to determine whether any of Stat3 activation by factors such as IL-6 transcriptionally activates HIF-1. HIF-1 levels are further regulated by oxygen tension and other metabolites, representing a key molecular link between metabolic cues and T cell lineage commitment. HIF-1 directly activates Rorc gene transcription and, furthermore, recruits p300 to RORgt transcription complexes on the promoters of T H 17 genes (i.e., Il17). These activities promote T H 17 differentiation. Concomitantly, HIF-1 induces Foxp3 protein degradation via targeting for ubiquitination and proteasomal degradation.
these inhibitors can alter the T H 17:T reg balance in vivo and ameliorate T H 17-dependent autoimmune diseases.
EXPERIMENTAL PROCEDURES Mice
All animal experiments were performed in specific pathogen-free facilities in the Johns Hopkins Animal Resource Center following national, state, and institutional guidelines. Animal protocols were approved by the Johns Hopkins Animal Care and Use Committee. Foxp3-GFP mice (Fontenot et al., 2005) were kindly provided by A. Rudensky. C57BL/6 HIF-1a fl/fl mice were produced in Dr. Semenza's lab. Rorc À/À mice were purchased from the Jackson Laboratory.
T Cell Differentiation
Naive T cells were purified using a FACS Aria sorter prior to stimulation with anti-CD3 /CD28 antibodies in a 24-well plate (1 and 4 mg/well, respectively; Biolegend) for 3-7 days. T H 17-skewing conditions consisted of IMDM media supplemented with 5% FBS, 20 ng/ml IL-6, 2.5 ng/ml TGFb (Peprotech), and 10 ug/ml neutralizing antibodies against IFNg, IL-4, and IL-12 (Biolegend).
For hypoxia experiments, cells were cultured in a GasPak Plus anaerobic chamber (1% O 2 ) for 20 hr cycles interrupted by normoxic rest.
Quantitative RT-PCR RNA was isolated by a miniRNA extraction kit (QIAGEN). The cDNA archival kit (Applied Biosystem) was used as per the manufacturer's instruction. Triplicate reactions were run using an ABI Prism 7500. mRNA levels were determined by comparative CT method and normalized to b-actin or 18 s rRNA expression.
EAE Induction
Six-to eight-week-old, sex-matched WT and T-HIF-1a À/À littermates were injected s.c in the rear flank with 100 mg MOG 35-55 peptide (2HN-MEVGWYRSPFSRVVHLYRNGK-COOH) in complete Freund's adjuvant (Sigma), and 250 ng pertussis toxin (List Biological) was injected i.p. Mice were monitored daily, and disease severity was scored.
Immunoprecipitation and Western Blotting
Immunoprecipitation and western blotting were performed as elsewhere (Pan et al., 2005) . Immunoprecipitations were done using a Pierce Crosslink IP kit and clean-Blot IP detection system (Thermo Scientific).
Reporter Gene Assays
The luciferase reporter gene assay reagents were obtained from Promega, and the assay was performed per manufacturer's instructions.
Chromatin Immunoprecipitation Assays
ChIP analysis was carried out according to the manufacturer's Millipore, Massachusetts, USA). Briefly, cells (1-/Millipore, Massachusetts, USA). The amount of immunoprecipitated DNA was quantified by real-time PCR with the ABI PRISM 7500 Sequence Detection System (Applied Biosystems) using SYBR Green. All primers used for ChIP assays are listed in Table S1 .
GST Pull-Down Cell lysate or purified protein was incubated with 3 mg of affinity-purified GST protein (with a GSTrap column, Amersham) in the presence of 0.2% BSA in BC100 Buffer on a rotator overnight at 4 C. Proteins were pulled down using GST beads, followed by washing, glutathione elution, and resolution by SDS-PAGE.
Statistical Analysis
An unpaired Student's t test was used to determine significance (*p < 0.05). 
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